• OPEN AN ACCOUNT
Indian Indices
Nifty
24,812.05 -41.35
(-0.17%)
Sensex
81,444.66 -138.64
( -0.17%)
Bank Nifty
55,828.75 114.60
( 0.21%)
Nifty IT
39,030.90 -325.20
( -0.83%)
Global Indices
Nasdaq
42,232.06 -304.04
(-0.71%)
Dow Jones
6,003.06 -51.05
(-0.84%)
Hang Seng
38,827.31 290.57
(0.75%)
Nikkei 225
8,843.47 9.44
(0.11%)
Forex
USD-INR
86.03 0.31
(0.36%)
EUR-INR
99.49 0.53
(0.53%)
GBP-INR
116.80 0.48
(0.41%)
JPY-INR
0.60 0.00
(0.27%)

EQUITY - MARKET SCREENER

Norris Medicines Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524414
INE744C01029
-14.7882648
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
18.84
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Waaree Renewable jumps on bagging major solar EPC contract
Jun 03,2025
The new contract is valued at approximately Rs 346.33 crore. The project, awarded by a domestic renewable generation company, involves the development of a ground-mount solar power plant with a capacity of 300 MW AC / 435 MW DC.

Waaree Renewable Technologies is tasked with completing the project within the financial year 2025-26, as per the terms stipulated in the LoA.

Waaree Renewable Technologies (WRTL) is subsidiary company of Waaree Group and spearheading the Solar EPC business. The company provides clean energy to its clients by setting up both on-site solar projects (rooftop and ground-mounted) and off-site solar farms (open access solar plants).

The company’s consolidated net profit jumped 82.7% to Rs 93.81 crore on 74.4% increase in revenue from operations to Rs 476.58 crore in Q4 FY25 over Q4 FY24.